Dermatology
| Psoriasis
Dermatology
Psoriasis
Apremilast improved patient-reported outcomes in patients with moderate to severe plaque psoriasis of the scalp: results of the phase 3, randomized STYLE study
book_2
Source:
EADV Virtual - Poster session
calendar_today
Published on Medfyle:
November 2020
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- Scalp psoriasis negatively impacts mental health, social functioning and quality of life.
- In the STYLE study, significantly greater proportions of patients achieved improvement of 4 points or more in scalp and whole-body itch compared to placebo.
- Over 16 weeks, quality of life was improved across many measures, including symptoms and feelings, and impact on daily activities, leisure, work and personal relationships.
Presenting Author
Read more
arrow_downward
Hide
arrow_upward
Linda Stein Gold, MD
Henry Ford Health System; West Bloomfield, MI, USA